These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 8787887)

  • 1. Ampicillin-sulbactam is effective in prevention and therapy of experimental endocarditis caused by beta-lactamase-producing coagulase-negative staphylococci.
    Ramos MC; Ing M; Kim E; Witt MD; Bayer AS
    Antimicrob Agents Chemother; 1996 Jan; 40(1):97-101. PubMed ID: 8787887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Beta-Lactam-beta-lactamase-inhibitor combinations are active in experimental endocarditis caused by beta-lactamase-producing oxacillin-resistant staphylococci.
    Hirano L; Bayer AS
    Antimicrob Agents Chemother; 1991 Apr; 35(4):685-90. PubMed ID: 2069374
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ampicillin, sulbactam, and rifampin combination treatment of experimental methicillin-resistant Staphylococcus aureus endocarditis in rabbits.
    Chambers HF; Kartalija M; Sande M
    J Infect Dis; 1995 Apr; 171(4):897-902. PubMed ID: 7706817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of ampicillin-sulbactam and oxacillin in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.
    Pefanis A; Thauvin-Eliopoulos C; Eliopoulos GM; Moellering RC
    Antimicrob Agents Chemother; 1993 Mar; 37(3):507-11. PubMed ID: 8460919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effective treatment of cephalosporin-rifampin combinations against cryptic methicillin-resistant beta-lactamase-producing coagulase-negative staphylococcal experimental endocarditis.
    Brandt CM; Rouse MS; Tallan BM; Laue NW; Wilson WR; Steckelberg JM
    Antimicrob Agents Chemother; 1995 Aug; 39(8):1815-9. PubMed ID: 7486924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of oxacillin and ampicillin-sulbactam combination in experimental endocarditis caused by beta-lactamase-hyperproducing Staphylococcus aureus.
    Thauvin-Eliopoulos C; Rice LB; Eliopoulos GM; Moellering RC
    Antimicrob Agents Chemother; 1990 May; 34(5):728-32. PubMed ID: 2360813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of experimental staphylococcal endocarditis due to a strain with reduced susceptibility in vitro to vancomycin: efficacy of ampicillin-sulbactam.
    Backo M; Gaenger E; Burkart A; Chai YL; Bayer AS
    Antimicrob Agents Chemother; 1999 Oct; 43(10):2565-8. PubMed ID: 10508047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of ampicillin-sulbactam with vancomycin for treatment of experimental endocarditis due to a beta-lactamase-producing, highly gentamicin-resistant isolate of Enterococcus faecalis.
    Lavoie SR; Wong ES; Coudron PE; Williams DS; Markowitz SM
    Antimicrob Agents Chemother; 1993 Jul; 37(7):1447-51. PubMed ID: 8363374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemoprophylactic efficacy against experimental endocarditis caused by beta-lactamase-producing, aminoglycoside-resistant enterococci is associated with prolonged serum inhibitory activity.
    Bayer AS; Tu J
    Antimicrob Agents Chemother; 1990 Jun; 34(6):1068-74. PubMed ID: 2118323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of trovafloxacin, a new quinolone antibiotic, in experimental staphylococcal endocarditis due to oxacillin-resistant strains.
    Bayer AS; Li C; Ing M
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1837-41. PubMed ID: 9661030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
    Ramos MC; Grayson ML; Eliopoulos GM; Bayer AS
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1864-9. PubMed ID: 1329632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Necrotising endocarditis of mitral valve due to Staphylococcus lugdunensis].
    Celebi G; Büyükateş M; Doğan SM; Pişkin N; Aydemir H; Oztoprak N; Aktaş E; Bektaş S; Keskin A; Akduman D
    Mikrobiyol Bul; 2009 Apr; 43(2):319-23. PubMed ID: 19621620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vancomycin or vancomycin plus netilmicin for methicillin- and gentamicin-resistant Staphylococcus aureus aortic valve experimental endocarditis.
    Perdikaris G; Giamarellou H; Pefanis A; Donta I; Karayiannakos P
    Antimicrob Agents Chemother; 1995 Oct; 39(10):2289-94. PubMed ID: 8619584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of cefoperazone in combination with sulbactam in experimental Staphylococcus aureus endocarditis in rabbits.
    Chambers HF; Fournier MA
    J Antimicrob Chemother; 1993 Sep; 32(3):453-8. PubMed ID: 8262867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative efficacies of liposomal amikacin (MiKasome) plus oxacillin versus conventional amikacin plus oxacillin in experimental endocarditis induced by Staphylococcus aureus: microbiological and echocardiographic analyses.
    Xiong YQ; Kupferwasser LI; Zack PM; Bayer AS
    Antimicrob Agents Chemother; 1999 Jul; 43(7):1737-42. PubMed ID: 10390232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of vancomycin plus rifampin in experimental aortic-valve endocarditis due to methicillin-resistant Staphylococcus aureus: in vitro-in vivo correlations.
    Bayer AS; Lam K
    J Infect Dis; 1985 Jan; 151(1):157-65. PubMed ID: 3965588
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Importance of penicillinase production for activity of penicillin alone or in combination with sulbactam in experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Fantin B; Pierre J; Castéla-Papin N; Saint-Julien L; Drugeon H; Farinotti R; Carbon C
    Antimicrob Agents Chemother; 1996 May; 40(5):1219-24. PubMed ID: 8723470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of ampicillin plus sulbactam against beta-lactamase producing enterococci in experimental endocarditis.
    Thal LA; Vazquez J; Perri MB; Beckley A; Donabedian S; Kaatz GW; Patterson JE; Zervos MJ
    J Antimicrob Chemother; 1993 Jan; 31(1):182-5. PubMed ID: 8444668
    [No Abstract]   [Full Text] [Related]  

  • 19. [Infective endocarditis due to high level aminoglycoside resistant Enterococcus faecalis and methicillin resistant coagulase-negative staphylococci presenting with rheumatic manifestations].
    Pişkin N; Akduman D; Aydemir H; Celebi G; Oztoprak N; Aktaş E
    Mikrobiyol Bul; 2008 Jul; 42(3):509-14. PubMed ID: 18822897
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment evaluation of experimental staphylococcal infections: comparison of beta-lactam, lipopeptide, and glycopeptide antimicrobial therapy.
    Fasching CE; Peterson LR; Moody JA; Sinn LM; Gerding DN
    J Lab Clin Med; 1990 Nov; 116(5):697-706. PubMed ID: 1967132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.